Kari J. Kurppa

2.3k total citations
31 papers, 817 citations indexed

About

Kari J. Kurppa is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kari J. Kurppa has authored 31 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kari J. Kurppa's work include HER2/EGFR in Cancer Research (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Hedgehog Signaling Pathway Studies (6 papers). Kari J. Kurppa is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Hedgehog Signaling Pathway Studies (6 papers). Kari J. Kurppa collaborates with scholars based in Finland, United States and United Kingdom. Kari J. Kurppa's co-authors include Klaus Elenius, Kristiina Heikinheimo, Javier Catón, Ari Ristimäki, Peter R. Morgan, Blandine Ruhin, Mark S. Johnson, Jari Kellokoski, Denis Tvorogov and Maria Sundvall and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Kari J. Kurppa

29 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari J. Kurppa Finland 13 486 427 296 234 100 31 817
Matthew R. Steensma United States 16 251 0.5× 53 0.1× 127 0.4× 271 1.2× 211 2.1× 36 797
Akimitsu Hiraki Japan 12 181 0.4× 30 0.1× 38 0.1× 251 1.1× 62 0.6× 21 528
Raul Perret France 13 357 0.7× 27 0.1× 111 0.4× 200 0.9× 235 2.4× 35 687
Emílio Marcelo Pereira Brazil 12 236 0.5× 75 0.2× 42 0.1× 420 1.8× 120 1.2× 19 915
Nicholas C. DeVito United States 13 374 0.8× 41 0.1× 62 0.2× 457 2.0× 123 1.2× 31 935
Lian‐He Yang China 16 383 0.8× 24 0.1× 31 0.1× 147 0.6× 148 1.5× 41 673
David S. Moura Spain 12 164 0.3× 42 0.1× 111 0.4× 248 1.1× 278 2.8× 49 532
Nel J. Kuipers‐Dijkshoorn Netherlands 15 275 0.6× 41 0.1× 88 0.3× 217 0.9× 125 1.3× 23 731
Motoshige Higashiyama Japan 9 263 0.5× 25 0.1× 63 0.2× 204 0.9× 160 1.6× 14 610
Lara Molendini Italy 13 295 0.6× 49 0.1× 167 0.6× 223 1.0× 353 3.5× 15 635

Countries citing papers authored by Kari J. Kurppa

Since Specialization
Citations

This map shows the geographic impact of Kari J. Kurppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari J. Kurppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari J. Kurppa more than expected).

Fields of papers citing papers by Kari J. Kurppa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari J. Kurppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari J. Kurppa. The network helps show where Kari J. Kurppa may publish in the future.

Co-authorship network of co-authors of Kari J. Kurppa

This figure shows the co-authorship network connecting the top 25 collaborators of Kari J. Kurppa. A scholar is included among the top collaborators of Kari J. Kurppa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari J. Kurppa. Kari J. Kurppa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zielińska, Karolina, Christian Koch, Francisco Caiado, et al.. (2025). The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis. Leukemia. 40(2). 279–292.
2.
Jokilammi, Anne, Pia Rantakari, Pauliina Kronqvist, et al.. (2024). Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo. ChemBioChem. 25(18). e202400264–e202400264. 1 indexed citations
3.
Mueller, Jan, Christian Koch, Florin Schneiter, et al.. (2024). Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO Molecular Medicine. 16(3). 445–474. 16 indexed citations
4.
Vogt, Andreas, Ilkka Paatero, Klaus Elenius, et al.. (2024). DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO Molecular Medicine. 16(7). 1603–1629. 9 indexed citations
5.
Fujii, Shinsuke, Kana Hasegawa, Takashi Maehara, et al.. (2024). Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication. Pathology - Research and Practice. 254. 155148–155148. 1 indexed citations
6.
Ruzicka, Regina, Laura L. Elo, Mark S. Johnson, et al.. (2022). An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations. Cancer Research Communications. 2(1). 10–27. 2 indexed citations
7.
Hasegawa, Kana, Shinsuke Fujii, Kari J. Kurppa, et al.. (2022). Clear cell squamous cell carcinoma of the tongue exhibits characteristics as an undifferentiated squamous cell carcinoma. Pathology - Research and Practice. 235. 153909–153909. 16 indexed citations
8.
Fujii, Shinsuke, Kana Hasegawa, Kari J. Kurppa, et al.. (2022). The Semaphorin 3A-AKT axis-mediated cell proliferation in salivary gland morphogenesis and adenoid cystic carcinoma pathogenesis. Pathology - Research and Practice. 236. 153991–153991. 6 indexed citations
9.
Kurppa, Kari J., et al.. (2021). Structural Basis for the Functional Changes by EGFR Exon 20 Insertion Mutations. Cancers. 13(5). 1120–1120. 12 indexed citations
10.
Johnson, Mark S., et al.. (2020). Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases. Molecular Cancer Therapeutics. 20(3). 564–576. 4 indexed citations
11.
Kurppa, Kari J., et al.. (2020). Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation. Journal of Visualized Experiments. 5 indexed citations
12.
Kurppa, Kari J., et al.. (2020). Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation. Journal of Visualized Experiments. 4 indexed citations
13.
Tvorogov, Denis, Shujun Lin, Jürgen Kast, et al.. (2020). The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration. Journal of Biological Chemistry. 295(33). 11559–11571. 12 indexed citations
14.
Kurppa, Kari J., Ilkka Paatero, Jussi Koivunen, et al.. (2019). An unbiased in vitro screen for activating epidermal growth factor receptor mutations. Journal of Biological Chemistry. 294(24). 9377–9389. 12 indexed citations
15.
Kurppa, Kari J., Konstantin Denessiouk, Mark S. Johnson, & Klaus Elenius. (2015). Activating ERBB4 mutations in non-small cell lung cancer. Oncogene. 35(10). 1283–1291. 54 indexed citations
16.
Wali, Vikram B., Maureen Gilmore-Hebert, Ramanaiah Mamillapalli, et al.. (2014). Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis. Breast Cancer Research. 16(6). 501–501. 24 indexed citations
17.
Heikinheimo, Kristiina, Kari J. Kurppa, Asta Laiho, et al.. (2014). Early Dental Epithelial Transcription Factors Distinguish Ameloblastoma from Keratocystic Odontogenic Tumor. Journal of Dental Research. 94(1). 101–111. 89 indexed citations
18.
Hollmén, Maija, Ping Liu, Kari J. Kurppa, et al.. (2012). Proteolytic Processing of ErbB4 in Breast Cancer. PLoS ONE. 7(6). e39413–e39413. 36 indexed citations
19.
Sundvall, Maria, Ville Veikkolainen, Kari J. Kurppa, et al.. (2010). Cell Death or Survival Promoted by Alternative Isoforms of ErbB4. Molecular Biology of the Cell. 21(23). 4275–4286. 49 indexed citations
20.
Kurppa, Kari J. & Klaus Elenius. (2009). Mutated ERBB4: a novel drug target in metastatic melanoma?. Pigment Cell & Melanoma Research. 22(6). 708–710. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew R. Steensma Breakdown of academic impact, for papers by Akimitsu Hiraki Breakdown of academic impact, for papers by Raul Perret Breakdown of academic impact, for papers by Emílio Marcelo Pereira Breakdown of academic impact, for papers by Nicholas C. DeVito Breakdown of academic impact, for papers by Lian‐He Yang Breakdown of academic impact, for papers by David S. Moura Breakdown of academic impact, for papers by Nel J. Kuipers‐Dijkshoorn Breakdown of academic impact, for papers by Motoshige Higashiyama Breakdown of academic impact, for papers by Lara Molendini
Rankless by CCL
2026